Filing metadata

Accession number
0001140361-21-010365
Form type
Form 4
Filer
Ernexa Therapeutics Inc.
CIK
CIK 748592
Filed
Mar 26, 2021
Reporting period
Mar 24, 2021
Description
Insider transaction

Explore SEC Filings Hub